A time-activity baseline to measure pharmacological and non- pharmacological manipulations of PCP-induced activity in mice

Psychopharmacology

Volumn 134, Issue 2, 1997, Pages 157-163

  McAllister, K H ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Ataxia; Chlordiazepoxide; Haloperidol; Locomotion; Mice; Pentobarbital; Phencyclidine (PCP); Time

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; HALOPERIDOL; PENTOBARBITAL; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA; DOPAMINE BLOOD LEVEL; ENVIRONMENT; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RODENT; STEREOTYPY; TREATMENT PLANNING;

ANIMALS; ANTI-ANXIETY AGENTS; CHLORDIAZEPOXIDE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GABA MODULATORS; HALOPERIDOL; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; PENTOBARBITAL; PHENCYCLIDINE; TIME FACTORS;

EID: 0030856207     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050437     Document Type: Article

References (27)

1. Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. Am J Psychiatry 135:1081-1084
2. Bakker CB, Amini FB (1961) Observations on the psychomimetic effects of Sernyl. Comp Psychiatry 2:269-280
3. Brunet BL, Reiffenstein RJ, Williams T, Wong L (1986) Toxicity of phencyclidine and ethanol in combination. Alcohol Drug Res 6:341-349
4. Castellani S, Adams PM (1981) Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol 73:143-154
5. Chait LD, Balster RL (1978) Interactions between phencyclidine and pentobarbital in several species of laboratory animals. Commun Psychopharmacol 2:351-356
6. Chen G, Ensor CR, Russell D, Bohner B (1959) The pharmacology of I-(1-phenycyclohexyl) piperidine. HCl. J Pharmacol Exp Ther 127:241-250
7. De Ryck M, Schallert T, Teitelbaum P (1980) Morphine versus haloperidol catalepsy in the rat: a behavioral analysis of postural support mechanisms. Brain Res 201:143-172
8. File SE, Hyde JRG (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19-24
9. Freed WJ, Weinberger DR, Bing LA, Wyatt RJ (1980) Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice. Psychopharmacology 71:291-297
10. Freed WJ, Bing LA, Wyatt RJ (1984) Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice. Neuropharmacology 23:175-181
11. Giannini AJ, Nageotte C, Loiselle RH, Malone DA, Price WA (1985) Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity. Clin Toxicol 22:573-579
12. Gleason SD, Shannon HE (1997) Blockade of phencyclidine induced hyperlocomotion by olanzepine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
13. Isaac W (1971) A study of the relationship between the visual system and the effects of d-amphetamine. Physiol Behav 6:157-159
14. Ivinskis A (1970) A study of the validity of open field measures. Aust J Psychol 22:175-183
15. Jackson DM, Johansson C, Lindgren L-M, Bengtsson A (1994) Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol Biochem Behav 48:465-471
16. Koek W, Woods JH, Ornstein P (1989) A simple and rapid method for assessing similarities among directly observable behavioural effects of drugs: PCP-like effects of 2-amino-5-phosphovalerate in rats. Psychopharmacology 91:297-304
17. Luby ED, Cohen BD, Rosenbaum F, Gottlieb J, Kelley R (1959) Study of a new schizophrenomimetic drug. Sernyl. Arch Neurol Psychiatry 81:363-369
18. Luisada PV, Brown BI (1976) Clinical management of the phencyclidine psychosis, Clin Toxicol 9:539-545
19. Maurel-Remy S, Bervoets K, Millan MJ (1995) Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5HT2A receptors. Eur J Pharmacol 280:R9-R11
20. Murray TF, Horita A (1979) Phencyclidine-induced stereotyped behavior in rats: dose response effects and antagonism by neuroleptics. Life Sci 24:2217-2226
21. Showalter CV, Thornton WE (1977) Clinical pharmacology of phencyclidine toxicity. Am J Psychiatry 134:1234-1238
22. Sturgeon RD, Fessler RG, London SF, Meltzer HY (1981) A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat. Eur J Pharmacol 76:37-53
23. Tai CY, Nabehima T, Sivam SP, Ho IK (1981) Effects of acute and continuous administration of pentobarbital on phencyclidine response. Res Commun Subst Abuse 2:239-252
24. Thompson DM, Moerschbaecher JM (1982) Phencyclidine in combination with pentobarbital: supra-additive effects on complex operant behavior in pigeons. Pharmacol Biochem Behav 17: 352-357
25. Wessinger WD, Balster RL (1987) Interactions between phencyclidine and central nervous system depressants evaluated in mice and rats. Pharmacol Biochem Behav 27:323-332
26. Winer BJ (1971) Statistical principles of experimental design. McGraw-Hill, New York
27. Woolverton WL, Balster RL (1981) Effects of combinations of phencyclidine and pentobarbital on fixed-interval performance in rhesus monkeys. J Pharmacol Exp Ther 217:611-618